We use cookies to customise content for your subscription and for analytics. If you continue to browse Lexology, we will assume that you are happy to receive all our cookies. For further information please read our Cookie Policy.
On January 5, 2011, the Minister of Health (Minister) refused to include THALOMID (thalidomide) on the Register of Innovative Drugs under the data protection provisions of the Food and Drug Regulations (DPR) due to the prior approval of thalidomide in the drugs KEVADON and TALIMOL
